At Calm/Storm, we believe the future of healthcare lies in prevention rather than treatment. Today, chronic diseases account for the majority of global healthcare costs, yet most systems still operate reactively waiting until illness strikes to intervene. Consumers, meanwhile, are increasingly looking for ways to take control of their health and optimise their longevity.

That’s why we’re excited to back Holo, a personalised health platform designed to empower individuals to proactively manage their wellbeing by consolidating lab data, wearable insights and imaging into one actionable dashboard.

From Reactive Treatment to Proactive Prevention

The traditional healthcare model focuses on fixing problems after they appear. Holo revolutionises this model by prioritising early detection, prevention and optimszation.

Users begin their journey with an initial lab test (blood and urine), receive a comprehensive personalised report within 48 hours and gain access to ongoing monitoring and tailored insights. Over time, Holo offers repeat testing, additional diagnostics and even performance-focused options for athletes. The result is a dynamic health profile that evolves with the user, enabling better decisions through clear and actionable insights.

With more than 100 biomarkers integrated into an intuitive digital profile, the platform gives individuals a clear and consolidated view of their health; something that is currently fragmented across clinics, labs and devices.

A Movement Ready to Scale

Preventive health and longevity are no longer niche. What used to feel like a conversation for scientists has now gone mainstream. Thanks to voices like Andrew Huberman, Peter Attia and a wave of podcasts and newsletters, more and more people are familiar with concepts like “bio-hacking” and “longevity.” Therefore, consumers are eager for tools that can help them put this knowledge into practice and that’s exactly what Holo is building.

The global market is valued at $3 billion today and projected to nearly double by 2030. Much of the innovation so far has been U.S.-centric with players, yet Europe remains a vastly underserved market. By combining fast product cycles with a consumer-friendly model, Holo is well-positioned to lead the charge in making proactive health accessible to a broader audience.

Proven Execution from a World-Class Team

At the heart of Holo’s potential is its founding team. Francesc, Emilio, and Sergio previously scaled Factorial HR from an early-stage startup into one of Europe’s leading SaaS unicorns. Their backgrounds span strategy, product design and engineering bringing exactly the blend of skills needed to build and scale a consumer-first health platform.

Beyond their individual expertise, what sets the founders apart is how well they work together. Having already built and scaled alongside each other this gives them a rare advantage as they take on the complex challenge of reshaping preventive health and longevity in Europe.

Why We Invested in Holo

At Calm/Storm, we back founders who challenge the status quo and tackle society’s most pressing challenges. Preventive health and longevity are among the defining shifts in healthcare, and Holo is building the tools to make this shift actionable and accessible.

With a strong product foundation, a scalable business model and a strong founding team, we believe Holo has the potential to become Europe’s category-defining player in preventive health. We’re proud to support Francesc, Emilio, and Sergio on this journey and excited to see Holo help people everywhere take health into their own hands!

‍